Skip to main content
SpringerLink
Log in

The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol

  • Animal Studies
  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Mice, administered haloperiodl (3 mg/kg/d) in their drinking water for 21 days, displayed, 4 days after cessation of the haloperidol-treatment, marked locomotor stimulation to clonidine (100 or 500 μg/kg) which lasted for about 6 h. 25 μg clonidine/kg was inactive. Premedication with FLA-63 (25 mg/kg) blocked the difference in stimulation after clonidine between the haloperidol- and vehicle-treated animals, but locomotor activity was still present in both groups. Haloperidol-treated animals displayed a supersensitive response to dexamphetamine. The difference in stimulation produced by dexamphetamine in the two groups was completely blocked by phenoxybenzamine (2.5 mg/kg), phentolamine (10 mg/kg), which drugs did not, however, block the locomotor stimulation produced by dexamphetamine in vehicle-treated animals. Pimozide (3 mg/kg) blocked all locomotor stimulation produced by dexamphetamine in both vehicle- and haloperidol-treated groups, while 1 mg/kg completely blocked the dexamphetamine response in vehicle-treated animals but not in haloperidol-treated animals. FLA-63 (25 mg/kg) blocked the difference in response between the haloperidol- and vehicletreated groups to dexamphetamine, but did not antagonise the stimulation in the vehicle-treated animals. The data suggest that long-term haloperidol treatment leads to the development of “supersensitive” adrenergic receptors in the central nervous system, which, appropriately stimulated, effect an increase in locomotor activity. Moreover, the results indicate that a large component of the supersensitive response to dexamphetamine observed after long-term haloperidol-treatment is due to adrenergic receptor supersensitivity. However, the dopamine receptor (which was shown to be supersensitive to apomorphine) is of fundamental importance because phenoxybenzamine and phenolamine, while blocking the supersensitive response to dexamphetamine, failed to block the response to dexamphetamine in vehicletreated animals, which was, however, blocked by pimozide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970)

    Google Scholar 

  • Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T.: Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513–523 (1970)

    Google Scholar 

  • Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamien receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967)

    Google Scholar 

  • Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)

    Google Scholar 

  • Angst, J., Bente, D., Berner, P., Heimann, H., Helmchen, H., Hippius, H.: Das klinische Wirkungsbild von Clozapin (Untersuchung mit dem AMP-System). Pharmakopsychiat. 4, 201–211 (1971)

    Google Scholar 

  • Asper, H., Baggiolini, M., Bürke, H. R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Europ. J. Pharmacol. 22, 287–294 (1973)

    Google Scholar 

  • Ayd, F. J.: Persistant dyskinesia: a neurologic complication of major tranquilizers. Med. Sci. 18, 32–40 (1967)

    Google Scholar 

  • Bartholini, G., Stadtler, H., Lloyd, K. G.: Cholinergic-dopaminergic relation in different brain structure. In: Frontiers in catecholamine research, E. Usdin and S. H. Snyder, eds., pp. 741–745. New York: Pergamon Press 1973

    Google Scholar 

  • Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. (Kbh.) 20, 140–144 (1963)

    Google Scholar 

  • Crane, G. E.: Tardive dyskinesia in patients treated with major neuroleptics. Amer. J. Psychiat. 124, 40–48 (1968)

    Google Scholar 

  • Degkwitz, R., Wenzel, W.: Zur Klinik der extrapyramidalen Hyperkinesen nach langfristiger Behandlung mit Neuroleptica. Nervenarzt 37, 368–370 (1966)

    Google Scholar 

  • Engel, J., Liljeqvist, S., Johannessen, K.: Behavioural effects of long-term treatment with antipsychotic drugs. In: Antipsychotic drugs, pharmacodynamics and pharmacokinetics, Y. Zotterman, B. Uvnäs and G. Sedvall, eds. New York: Pergamon Press (in press)

  • Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967)

    Google Scholar 

  • Fann, W. E., Lake, C. R.: Cholinergic suppression of tardive dyskinesia. Psychopharmacologia (Berl.) 37, 101–107 (1975)

    Google Scholar 

  • Faurbye, A., Rasch, P.-J., Bender-Petersen, P., Brandborg, G., Pakkenberg, H.: Neurological symptoms in pharmacology of psychosis. Acta physiol. scand. 40, 10–26 (1964)

    Google Scholar 

  • Ferris, R. M., Tang, F. L. M., Maxwell, R. A.: A comparison of the capacities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J. Pharmacol. exp. Ther. 181, 407–416 (1972)

    Google Scholar 

  • Fialland, B., Møller-Nielsen, I.: Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptics. Psychopharmacologia (Berl.) 34, 105–109 (1974)

    Google Scholar 

  • Gianutsos, G., Drawbaugh, R. B., Hynes, M. D., Lal, H.: Behavioural evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci. 14, 887–898 (1974)

    Google Scholar 

  • Gianutsos, G., Hynes, M. D., Lal, H.: Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol. Biochem. Pharmacol. 24, 581–582 (1975)

    Google Scholar 

  • von Gross, H., Langner, E.: Das Wirkungsprofil eines chemisch neuartigen Breitbandneuroleptikums der Dibenzdiazepingruppe. Wien. med. Wschr. 116, 814–816 (1966)

    Google Scholar 

  • von Gross, H., Langner, E.: Das Neuroleptikum 100-129/HF 1854 (Clozapin) in der Psychiatrie. Intern. Pharmakopsychiat. 4, 220–224 (1970)

    Google Scholar 

  • Heikkila, R. E., Orlansky, H., Mytilineou, C., Cohen, G.: Amphetamine: Evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J. Pharmacol. exp. Ther. 193, 47–56 (1975)

    Google Scholar 

  • Horn, A. S., Snyder, S. H.: Chlorpromazine and dopamine: Conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc. nat. Acad. Sci. (Wash.) 68, 2325–2328 (1971)

    Google Scholar 

  • Jackson, D. M.: The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by β-phenethylamine. J. Pharm. Pharmacol. 26, 651–654 (1974)

    Google Scholar 

  • Jackson, D. M., Andén, N.-E., Engel, J., Liljeqvist, S.: The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum. Psychopharmacologia (Berl.) 45 151–155 (1975)

    Google Scholar 

  • Klawans, H. L., Rubovits, R.: An experimental model of tardive dyskinesia. J. neurol. Trans. 33, 235–246 (1972)

    Google Scholar 

  • de Maio, D.: Clozapine, a novel major tranquillizer. Arzneimittel-Forsch. 22, 919–923 (1972)

    Google Scholar 

  • Maj, J., Sowińska, H., Baran, L., Kapturkiewicz, Z.: The effect of clonidine on locomotor activity in mice. Life Sci 11, 483–491 (1972)

    Google Scholar 

  • Mantegazza, P., Naimzada, K. M., Riva, M.: Effects of propranolol on some activities of amphetamine. Europ. J. Pharmacol. 4, 25–30 (1968)

    Google Scholar 

  • Persson, T., Waldeck, B.: Further studies on the possible interactions between dopamine and noradrenaline containing neurons in the brain. Europ. J. Pharmacol. 11, 315–320 (1970)

    Google Scholar 

  • Puri, S. K., Lal, H.: Tolerance to the behavioural and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 155–170 (1974)

    Google Scholar 

  • van Rossum, J. M.: Significance of dopamine-receptor blockade for mechanism of action of neuroleptic drugs. Arch. int. Pharm. 160, 492–494 (1966)

    Google Scholar 

  • Sayers, A. C., Bürki, H. R., Ruch, W., Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia (Berl.) 41, 97–104 (1975)

    Google Scholar 

  • Schelkunov, E. L.: Adrenergic effect of chronic administration of neuroleptics. Nature (Lond.) 214, 1210–1212 (1967)

    Google Scholar 

  • Snyder, S., Greenberg, D., Yamamura, H. I.: Antischizophrenic drugs and brain cholinergic receptors—affinity for muscarinic sites predicts extrapyramidal side effects. Arch. gen. Psychiat. 31, 58–61 (1974)

    Google Scholar 

  • Stille, G., Hippius, H.: Kritische Stellungnahme zum Begriff der Neuroleptika (anhand von pharmakologischen und klinischen Befunden mit Clozapin). Pharmakopsychiat. 4, 182–191 (1971)

    Google Scholar 

  • Svensson, T. H.: Functional and biochemical effects of d- and l-amphetamine on central catecholamine neurons. Naunyn-Schmiedeberg's Arch. Pharmak. 271, 170–180 (1970)

    Google Scholar 

  • Svensson, T. H., Bunney, B. S., Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. (1975)

  • Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfer with the synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)

    Google Scholar 

  • Thornburg, J. E., Moore, K. E.: Supersensitivity to dopaminergic agonists following withdrawal of a chronic diet containing haloperidol or pimozide. Pharmacologist 16, 307 (1974)

    Google Scholar 

  • Thornburg, J. E., Moore, K. E.: Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice. J. Pharmacol. exp. Ther. 192, 42–49 (1975)

    Google Scholar 

  • Ungerstedt, U.: Post-synaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta physiol. scand., Suppl. 367, 69–93 (1971)

    Google Scholar 

  • von Voigtlander, P. F., Losey, E. G., Triezenberg, H. J.: Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J. Pharmacol. exp. Ther. 193, 88–94 (1975)

    Google Scholar 

  • von Voigtlander, P. F., Moore, K. E.: Turning behaviour of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, l-Dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmacology 12, 451–462 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of pharmacology, University of Sydney, Sydney, Australia

    Robin Dunstan & David M. Jackson

Authors
  1. Robin Dunstan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David M. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunstan, R., Jackson, D.M. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 48, 105–114 (1976). https://doi.org/10.1007/BF00423315

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00423315

Key words

Search

Navigation